Haolong Qi

Dr. Haolong Qi


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2015 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
HQHaolong Qi
Haolong Qi
CLChang-Sheng Li
Chang-Sheng Li
CQChong-Wei Qian
Chong-Wei Qian
YXYu-Sha Xiao
Yu-Sha Xiao
YYYu-Feng Yuan
Yu-Feng Yuan
QLQuanyan Liu
Quanyan Liu

8 March 2024 in Oncology Letters
Verified
Journal Article
Open access
PDF file
LZLei Zhu
Lei Zhu
JZJie Zhang
Jie Zhang
HZHongxia Zhou
Hongxia Zhou
GZGuanqi Zhang
Guanqi Zhang
BWBin Wang
Bin Wang
HQHaolong Qi
Haolong Qi
The novel long non‑coding RNA, EGFR‑AS1, is expressed in various types of solid tumour, and its oncogenic role has been fully identified. In the present study, several articles were screened following an electronic search of the PubMed database. In total, 8 studies were included in the present systematic review. For each analysis indicator risk ratios (RRs) with 95% confidence intervals (CIs) or hazard ratios (HRs) with standard errors and 95% CIs were estimated using Review Manager 5.3. The pooled RR of high EGFR‑AS1 expression among patients with or without vascular invasion was 1.81 with a 95% CI of 1.22‑2.69; the pooled HR of high EGFR‑AS1 expression for patient overall survival rate was 1.74 with a 95% CI of 1.39‑2.18. Therefore, EGFR‑AS1 was identified as an oncogene and the upregulated EGFR‑AS1 expression was significantly associated with advanced tumour progression and poor prognosis.

31 December 2025 in Research Square
Verified
Preprint
Open access
PDF file
LLLei Lei
Lei Lei
QHQi Han
Qi Han
BPBei Pei
Bei Pei
JZJie Zhang
Jie Zhang
HQHaolong Qi
Haolong Qi
Background: Gastroparesis is a debilitating disorder characterized by delayed gastric emptying without mechanical obstruction, carrying significant mortality risks. Accurate prediction of mortality remains challenging due to the condition's heterogeneous nature. This study aimed to develop and validate machine learning models for predicting both short-term and long-term mortality in patients with gastroparesis. Methods: This retrospective cohort study utilized data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. Adult patients diagnosed with gastroparesis between 2003 and 2019 were included. Comprehensive clinical data encompassing demographics, laboratory parameters, comorbidities, and severity scores were extracted. Seven machine learning algorithms were employed to predict 30-day and 365-day mortality: logistic regression, support vector machine, random forest, k-nearest neighbors, decision tree, artificial neural network, and gradient boosting machine. Model performance was evaluated using area under the receiver operating characteristic curve (AUC-ROC), accuracy, precision, recall, and F1-score. Results: Among 6,125 eligible patients with gastroparesis, the random forest model demonstrated superior performance for both 30-day (AUC: 0.39) and 365-day mortality prediction (AUC: 0.905). Key predictors included age, red cell distribution width (RDW), Charlson comorbidity index, white blood cell count, and renal function markers. Significant mortality associations were identified for ICU admission, sepsis, acute kidney injury, and liver diseases. Conclusions: Machine learning algorithms, particularly random forest, effectively predict mortality risk in gastroparesis patients using routinely available clinical data. These models provide valuable tools for risk stratification and informed clinical decision-making, potentially improving patient outcomes through early identification of high-risk individuals.